[go: up one dir, main page]

ES263036U - Estructura de pastilla. - Google Patents

Estructura de pastilla.

Info

Publication number
ES263036U
ES263036U ES1980263036U ES263036U ES263036U ES 263036 U ES263036 U ES 263036U ES 1980263036 U ES1980263036 U ES 1980263036U ES 263036 U ES263036 U ES 263036U ES 263036 U ES263036 U ES 263036U
Authority
ES
Spain
Prior art keywords
tablet
score markings
fractionable
markings
score
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES1980263036U
Other languages
English (en)
Other versions
ES263036Y (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26698095&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES263036(U) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/024,139 external-priority patent/US4215104A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ES263036U publication Critical patent/ES263036U/es
Application granted granted Critical
Publication of ES263036Y publication Critical patent/ES263036Y/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Estructura de pastilla multifraccionable para uso medicinal que incluye un cuerpo unitario, caracterizada porque el cuerpo unitario tiene unas primera y segunda superficies sustancialmente horizontales dispuestas en oposición que unidas respectivamente por unas paredes sustancialmente verticales; conteniendo una cualquiera de dicha primera superficie horizontal o dicha segunda superficie horizontal, o dichas paredes sustancialmente verticales por lo menos dos marcas transversales en forma de incisión y conteniendo por lo menos otra de dichas superficies o paredes una sola marca transversal en forma de incisión, con lo cual el cuerpo unitario puede romperse por lo meros en dos secciones iguales o en tres secciones iguales.
ES1980263036U 1979-03-26 1980-03-25 Estructura de pastilla. Expired ES263036Y (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/024,139 US4215104A (en) 1979-03-26 1979-03-26 Multi-fractionable tablet structure
US06/121,615 US4258027A (en) 1979-03-26 1980-02-14 Multi-fractionable tablet structure

Publications (2)

Publication Number Publication Date
ES263036U true ES263036U (es) 1982-11-01
ES263036Y ES263036Y (es) 1984-04-01

Family

ID=26698095

Family Applications (1)

Application Number Title Priority Date Filing Date
ES1980263036U Expired ES263036Y (es) 1979-03-26 1980-03-25 Estructura de pastilla.

Country Status (26)

Country Link
US (1) US4258027A (es)
AT (1) AT372853B (es)
AU (1) AU533115B2 (es)
CA (1) CA1133393A (es)
CH (1) CH644515A5 (es)
CY (1) CY1311A (es)
DE (1) DE3011680C2 (es)
DK (1) DK155566C (es)
ES (1) ES263036Y (es)
FI (1) FI800884A (es)
FR (1) FR2452284A1 (es)
GB (1) GB2047095B (es)
GR (1) GR67751B (es)
HK (1) HK92985A (es)
HU (1) HU191022B (es)
IE (1) IE49579B1 (es)
IL (1) IL59697A (es)
IT (1) IT1143959B (es)
KE (1) KE3571A (es)
LU (1) LU82297A1 (es)
MY (1) MY8600287A (es)
NL (1) NL189175C (es)
NO (1) NO157048C (es)
PH (1) PH16802A (es)
SE (1) SE446061B (es)
YU (1) YU42100B (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
US4465660A (en) * 1981-04-01 1984-08-14 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
DE3610878A1 (de) * 1986-04-01 1987-10-08 Boehringer Ingelheim Kg Formlinge aus pellets
US4793493A (en) * 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4735805A (en) * 1987-03-11 1988-04-05 The Upjohn Company Bisectable drug tablet
US5009896A (en) * 1989-10-04 1991-04-23 Akzo N.V. Multi-fractionable tablet structure
US5061494A (en) * 1990-06-14 1991-10-29 The Upjohn Comany Tri-scored drug tablet
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
DK0531964T3 (da) * 1991-09-10 1999-09-27 Takeda Chemical Industries Ltd Delelig tablet
DE4342146C1 (de) * 1993-12-10 1995-07-06 Notter Gmbh Ringtablette
DE9415022U1 (de) * 1994-09-15 1994-11-17 Azupharma GmbH, 70839 Gerlingen Tablettenartiger Körper mit Bruchkerbe
US5756124A (en) * 1995-08-07 1998-05-26 Invamed, Inc. Multi-scored pharmaceutical tablets
GB9624563D0 (en) * 1996-11-27 1997-01-15 Smithkline Beecham Plc Product
DE19837684A1 (de) * 1998-08-19 2000-02-24 Knoll Ag Exakt teilbare Tablette
GB9914620D0 (en) * 1999-06-23 1999-08-25 Eu Pharma Ltd Divisible tablets
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
TW200502000A (en) * 2003-03-28 2005-01-16 Kyowa Hakko Kogyo Kk Dividing tablet
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
FR2859632B1 (fr) * 2003-09-15 2005-11-18 Arrow Generiques Comprime multisecable a observance amelioree.
US8157788B2 (en) * 2003-11-06 2012-04-17 Paolo L. Manfredi Multi-site drug delivery platform
US7838031B2 (en) * 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
EP1755563B1 (en) 2004-05-21 2012-01-25 Accu-Break Technologies, Inc. Pharmaceutical tablets comprising two or more unitary segments
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
CN102008392B (zh) * 2005-08-18 2013-07-31 帝人制药株式会社 具有准确的用量分割功能的制剂
US20090280171A1 (en) * 2006-04-13 2009-11-12 Accu-Break Technologies, Inc. Method of treatment with predictably breakable pharmaceutical tablets
US20080264430A2 (en) * 2006-11-21 2008-10-30 Edmund Roschak Methods and devices for accessing the heart
US7985419B1 (en) 2006-12-22 2011-07-26 Watson Laboratories, Inc. Divisible tablet and associated methods
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
BRPI0912014A2 (pt) 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
MX2012000317A (es) 2009-07-22 2012-02-08 Gruenenthal Gmbh Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
WO2011009603A1 (en) 2009-07-22 2011-01-27 Grünenthal GmbH Tamper-resistant dosage form for oxidation-sensitive oploids
AR082862A1 (es) 2010-09-02 2013-01-16 Gruenenthal Gmbh Forma de dosificacion resistente a alteracion que comprende un polimero anionico
KR20130097202A (ko) 2010-09-02 2013-09-02 그뤼넨탈 게엠베하 무기 염을 포함하는 내변조성 투여형
US8383135B2 (en) 2010-12-03 2013-02-26 Richard C. Fuisz Solid dosage form that promotes reliable oral, esophageal and GI transit
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
AU2012292418B2 (en) 2011-07-29 2017-02-16 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
AU2013225106B2 (en) 2012-02-28 2017-11-02 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
EA201401139A1 (ru) 2012-04-18 2015-03-31 Грюненталь Гмбх Устойчивая к разрушению и к сбросу дозы фармацевтическая лекарственная форма
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
WO2015004245A1 (en) 2013-07-12 2015-01-15 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
MX371372B (es) 2013-11-26 2020-01-28 Gruenenthal Gmbh Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP6903659B2 (ja) 2015-08-21 2021-07-14 アプレシア・ファーマスーティカルズ・エルエルシー ３次元プリントシステムおよび装置アセンブリ
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
DE102016119675A1 (de) 2016-10-14 2018-04-19 Ritter Pharma-Technik Gmbh Tablette mit Bruchwinkel und senkrecht zur Pressrichtung eingebrachter Teilungskerbe
USD827721S1 (en) * 2017-03-15 2018-09-04 Click-Block Corporation Triangular tile magnetic toy
USD906294S1 (en) * 2019-01-28 2020-12-29 Compal Electronics, Inc. Set of earbuds
JP1640288S (es) * 2019-02-08 2019-09-02
JP1637715S (es) * 2019-02-08 2019-07-29
JP1637714S (es) * 2019-02-08 2019-07-29
US20210378968A1 (en) * 2020-05-28 2021-12-09 Johnson & Johnson Consumer Inc. Multi-cavity customizable dosage forms

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US94644A (en) * 1869-09-07 Improvement in horse hat-forks
FR438385A (fr) * 1911-01-02 1912-05-15 Fernande Barry Le Grand Bijoux et parures en bonbons et pates de fruits ou toute autre pate
US1836604A (en) * 1929-06-01 1931-12-15 Simon M Meyer Sugar unit
US2052376A (en) * 1933-05-18 1936-08-25 Edgar G Zellers Insoluble pill or tablet for internal medicinal uses
DE1200790B (de) * 1961-12-06 1965-09-16 Thomas L Cooper Zerlegbare Tablette
GB993291A (en) * 1961-12-06 1965-05-26 Thomas Lee Cooper Tablets, pills, pellets and the like
US3336200A (en) * 1963-05-28 1967-08-15 Warner Lambert Pharmaceutical Tablet structure
CH502891A (de) * 1967-11-21 1971-02-15 Ciba Geigy Ag Technische, gekerbte Tablette
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
GB1368574A (en) * 1971-02-12 1974-10-02 Ives Lab Inc Divisible tablet
GB1387643A (en) * 1971-03-16 1975-03-19 Ives Lab Inc Divisible tablet
US3883647A (en) * 1972-12-06 1975-05-13 Ives Lab Tablet formulation

Also Published As

Publication number Publication date
SE446061B (sv) 1986-08-11
GB2047095B (en) 1983-08-24
NL8001700A (nl) 1980-09-30
YU42100B (en) 1988-04-30
PH16802A (en) 1984-03-01
NO157048C (no) 1988-01-27
CA1133393A (en) 1982-10-12
SE8002303L (sv) 1980-09-27
IE49579B1 (en) 1985-10-30
NL189175C (nl) 1993-02-01
FR2452284A1 (fr) 1980-10-24
FI800884A (fi) 1980-09-27
CY1311A (en) 1986-03-28
US4258027A (en) 1981-03-24
MY8600287A (en) 1986-12-31
GR67751B (es) 1981-09-18
DE3011680C2 (de) 1997-04-30
AU533115B2 (en) 1983-11-03
IE800612L (en) 1980-09-26
IT8048241A0 (it) 1980-03-24
NO157048B (no) 1987-10-05
IL59697A0 (en) 1980-06-30
IT1143959B (it) 1986-10-29
CH644515A5 (de) 1984-08-15
ES263036Y (es) 1984-04-01
HK92985A (en) 1985-11-29
DK128580A (da) 1980-09-27
LU82297A1 (fr) 1980-10-08
YU77280A (en) 1983-04-30
AT372853B (de) 1983-11-25
FR2452284B1 (es) 1983-06-17
DK155566B (da) 1989-04-24
AU5647480A (en) 1980-10-02
NL189175B (nl) 1992-09-01
KE3571A (en) 1985-11-08
DK155566C (da) 1989-09-11
ATA160880A (de) 1983-04-15
IL59697A (en) 1983-11-30
DE3011680A1 (de) 1980-10-09
NO800847L (no) 1980-09-29
HU191022B (en) 1986-12-28
GB2047095A (en) 1980-11-26

Similar Documents

Publication Publication Date Title
ES263036U (es) Estructura de pastilla.
DK409586A (da) Tablet med reguleret afgivelse samt fremgangsmaade til fremstilling deraf
ZA848369B (en) Pharmaceutical compositions containing bilobalid for the treatment of neuropathies
DK462486A (da) Farmaceutisk tablet indeholdende cefuroxim-axetil
MY8700761A (en) Novel antihistamines process for their preparation and pharmaceutical compositions containing them
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
DE3070189D1 (en) Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
PH15398A (en) Novel excipient and pharmaceutical composition containing the same
DK40986D0 (da) 4h-1-benzopyran-4-oner og deres svovlholdige analoge, og farmaceutiske kompositioner indeholdende forbindelserne
DE3068803D1 (en) The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them
US5225203C1 (en) Pharmaceutical liquid composition containing bezoar bovis
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
DE3677342D1 (de) Geraet zur anzeige von augenleiden.
JPS55113800A (en) Muramyllpeptide type comound and drug containing it
ATE77750T1 (de) Antisaeurezusammensetzung.
ATE97001T1 (de) Topisch anzuwendende defibrotid enthaltende arzneizubereitungen.
IT1157348B (it) Composizione e procedimento per la stabilizzare le bevande contro la formazione di introbidimento
DK399985A (da) 6-substituerede mitomycin-analoge, deres anvendelse inden for medicinen og kompositioner indeholdende forbindelserne
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
IT8123270A0 (it) Imidazol-eteri ed esteri, procedimenti per prepararli e composizioni farmaceutiche che licontengono.
DK259586A (da) Farmaceutisk tablet
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
PH16250A (en) Pharmaceutical composition of therapeutic value in the treatment of some shock conditions
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.
EP0300036A4 (en) PHARMACEUTICAL COMPOSITIONS BASED ON VASOPRESSIN.

Legal Events

Date Code Title Description
FD1K Utility model lapsed

Effective date: 20000503